About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Unequivocal Good News | Main | Europe, Again »

December 1, 2002

Place Your Bets

Email This Entry

Posted by Derek

Something I mentioned in a post last week got me thinking. . .does anyone want to put some money down on whether the European Union will accept the new strain of rice I was speaking about? After all, it's genetically engineered, no doubt about it - what's more, it has genes that didn't even come from plants at all, but were spliced in from bacteria. Sounds just like the sort of thing that they've been putting their feet down about.

That wouldn't be much of a problem, normally - not a heck of a lot of rice gets grown in Europe (well, Arborio strains in Italy, yeah, but most of the rest of the continent isn't really warm enough.) And its not like the enhanced cold tolerance of the new plants will convince European farmers to start growing it, either, because - genetic fears aside - the EU already produces more food than it knows what to do with.

No, the problem is that other, poorer, countries have been leery of growing genetically modified crops because they trade with the EU. And the Europeans are worried that some of these modified strains might make it, by mistake, into their own countries. You may have read about Zambia (not a country that can really afford to turn down free food) rejecting offers of grain from the US because of fears of European retaliation. A recent effort by Denmark has dragged several other European countries, kicking and screaming, into accepting small amounts of inadvertantly mixed genetically-modified grain, but at a very strict level. Perhaps more African nations will feel safe to feed their starving populations with free food, once everyone in Brussels thinks about the situation a while longer in some really good restaurants. (A cheap shot, I know, but this sort of thing really gets on my nerves.)

So, how about it? Will Europe nervously sidle away from evil Franken-rice - part grain, part bacteria, all terrifying? Or will they have come slightly back to their senses by the time this livesaving innovation is released to the public domain?

Comments (0) + TrackBacks (0) | Category: General Scientific News



Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry